| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |